Mobile App Intervention for Informal Dementia Caregivers

February 6, 2024 updated by: Yuan Qi, Institute of Mental Health, Singapore

Design and Pilot-test of an Innovative Mobile-based Intervention to Promote Mental Health of Informal Dementia Caregivers Through User-Centered Design

Informal caregivers of persons with dementia (PWD) usually experience elevated levels of caregiving burden and potential depression. This project aims to develop and pilot-test a mobile app intervention for informal caregivers of PWD in Singapore. The project will have three phases in total including 1) phase 1 - to develop the app prototype and collect feedback from caregivers via focused group discussions. 2) a pilot RCT with 60 participants in total - 30 will be required to use the app for one month while another 30 will be on a waiting list for one month. and 3) in-depth interviews to seek users' feedback on the app for its future improvements. We hypothesize that the mobile app designed through a user-centered process would lead to high acceptance and high user engagement among local dementia caregivers. The 1-month intervention using the app developed subsequently would lower the reported depressive symptoms among local dementia caregiver. It will also improve their knowledge of dementia, caregiving efficacy, positive coping strategy, perceived positive aspects of caregiver and social support, and their mental well-being; and reduce their caregiving burden, and level of anxiety, compared to the control group.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The prevalence of dementia was found to be 10% among residents aged 60 years and above in Singapore according to the Well-being of the Singapore Elderly study, equivalent to 51,934 older adults. As the population is aging in Singapore, and the fact that the incidence of dementia doubles with every 6.3-year increase in age after 60 years old, this number is going to grow as well, together with an increasing number of their informal caregivers. Informal caregivers of persons with dementia (PWD) usually experience elevated levels of caregiving burden from supporting the daily functioning of the PWD as well as issues such as work-family-caregiving conflicts and social isolation. These stressors can lead to potential depression among informal caregivers. The aggregate prevalence of depression was reported to be 34% according to a previous meta-analysis. Due to their heavy involvement in daily caregiving, caregivers usually have difficulties in attending face-to-face interventions. For instance, the average weekly hours spent on caregiving were reported to be 55 hours in our recent study among local informal caregivers. And this situation might be even worse in the current COVID-19 outbreak. To better support them now and in the future, an alternative could be to rely on a mobile-based intervention, as the penetration rate of smartphones among local residents is quite high (aged 15-49: >95%, aged 50-59: 88%, and aged 60 and above: 56%). Several studies have strengthened the evidence that these methods are feasible and acceptable among dementia caregivers. And preliminary evidence also suggested that such interventions were viable and potentially effective in promoting the mental health status among informal dementia caregivers.

This study aims to address the following gaps - Firstly, there is a lack of user-centered design in app development as well as rigorously designed studies based on a clear theoretical framework for dementia caregivers. Secondly, none of the existing evidence-based mobile apps for supporting dementia caregivers is Singapore-based. Lastly, a mobile-based intervention developed with culturally relevant knowledge, support, and resources is needed for local dementia caregivers, especially seeing the current Covid-19 outbreak and the new normal in the future.

Primary Objective The current study aims to design and develop a mobile-based multi-component intervention (i.e. an app) to promote mental health among informal caregivers of individuals with dementia in Singapore, and pilot-test the effectiveness of the app among a convenience sample of local informal dementia caregivers.

Secondary Objective(s) Secondary objectives include 1) seeking users' feedback and identifying areas for future improvements; 2) exploring the potential for future bigger trials; 3) providing a development framework for future similar programs.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Singapore, Singapore, 539747
        • Recruiting
        • Clinic B, Institute of Mental Health
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. aged 21 or above;
  2. Singapore citizen or permanent resident;
  3. primary caregiver who is currently taking care of a PWD;
  4. scores 4 and above using the 4-item screening version Zarit Burden Interview;
  5. has sufficient skills in using mobile apps;
  6. able to read, write, and speak in English

Exclusion Criteria:

  1. Caregivers who are pregnant
  2. caregivers with vision and hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
To use the mobile app developed by the study team for one month. The app has a few key features including a positive reflection journal, online peer support, knowledge sharing, self-assessment, and locally available resources. Participants in the intervention group will be required to complete at least two positive reflection journal entries per week, and will be encouraged to use other features of the app during the one month period.
Please refer to the previous session
No Intervention: Wait list
Participants in this group will be put on a wait-list for one month before they can use the app.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline depressive symptom
Time Frame: baseline - before the intervention
Centre for Epidemiological Study Scale (0-60), with a higher score indicating a more severe depressive symptom
baseline - before the intervention
Post-intervention depressive symptom
Time Frame: within 2 weeks after the intervention
Centre for Epidemiological Study Scale (0-60), with a higher score indicating a more severe depressive symptom
within 2 weeks after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline knowledge of dementia
Time Frame: baseline - before the intervention
Dementia Knowledge Assessment Scale (0-54), with higher score indicating better knowledge on dementia
baseline - before the intervention
Post intervention knowledge of dementia
Time Frame: within 2 weeks after the intervention
Dementia Knowledge Assessment Scale (0-54), with higher score indicating better knowledge on dementia
within 2 weeks after the intervention
Baseline caregiving self-efficacy
Time Frame: baseline - before the intervention
Revised Scale for Caregiving Self-efficacy (0-100), with higher score indicating more confidence in caregiving
baseline - before the intervention
Post intervention caregiving self-efficacy
Time Frame: within 2 weeks after the intervention
Revised Scale for Caregiving Self-efficacy (0-100), with higher score indicating more confidence in caregiving
within 2 weeks after the intervention
Baseline coping strategy
Time Frame: baseline - before the intervention
brief Coping Orientation to Problems Experienced inventory - it has a total of 14 subscales, for each subscale higher score indicating more frequent usage of that specific coping strategy
baseline - before the intervention
Post intervention coping strategy
Time Frame: within 2 weeks after the intervention
brief Coping Orientation to Problems Experienced inventory - it has a total of 14 subscales, for each subscale higher score indicating more frequent usage of that specific coping strategy
within 2 weeks after the intervention
Baseline positive aspects of caregiving
Time Frame: baseline - before the intervention
Positive Aspects of Caregiving Scale (9-45) - with a higher score indicates a more positive caregiving experience
baseline - before the intervention
Post intervention positive aspects of caregiving
Time Frame: within 2 weeks after the intervention
Positive Aspects of Caregiving Scale (9-45) - with a higher score indicates a more positive caregiving experience
within 2 weeks after the intervention
Baseline caregiver burden
Time Frame: baseline - before the intervention
Zarit burden interview (0-88) - with a higher score indicating higher perceived caregiving burden
baseline - before the intervention
Post intervention caregiver burden
Time Frame: within 2 weeks after the intervention
Zarit burden interview (0-88) - with a higher score indicating higher perceived caregiving burden
within 2 weeks after the intervention
Baseline anxiety level
Time Frame: baseline - before the intervention
Generalized Anxiety Disorder 7-item scale (0-21) - with a higher score indicating higher anxiety level
baseline - before the intervention
Post intervention anxiety level
Time Frame: within 2 weeks after the intervention
Generalized Anxiety Disorder 7-item scale (0-21) - with a higher score indicating higher anxiety level
within 2 weeks after the intervention
Baseline mental well-being
Time Frame: baseline - before the intervention
Short Positive Mental Health instrument (1-6) - with a higher score indicating higher positive mental health
baseline - before the intervention
Post intervention mental well-being
Time Frame: within 2 weeks after the intervention
Short Positive Mental Health instrument (1-6) - with a higher score indicating higher positive mental health
within 2 weeks after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Qi Yuan, PhD, Research Division, Institute of Mental Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

September 16, 2022

First Submitted That Met QC Criteria

September 20, 2022

First Posted (Actual)

September 22, 2022

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Our IRB requires a signed research collaboration agreement before we can share the data. Parties who are interested in the current study can write in to inquire about the procedures.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Kampung Care App

3
Subscribe